A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D management: colesevelam HCL

Journal article

Peer reviewed

Current diabetes reports, Vol.9(5), pp.331-332

2009-10

PMID: 19793501

Abstract

Cardiotonic Agents - therapeutic use

Hypoglycemic Agents - therapeutic use

Anticholesteremic Agents - therapeutic use

Humans

Allylamine - analogs & derivatives

Cholesterol, LDL - metabolism

Bile Acids and Salts - metabolism

Allylamine - therapeutic use

Diabetes Mellitus, Type 2 - drug therapy

Colesevelam Hydrochloride

22 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.26 Diabetes; 1.26.42 Diabetes
Web Of Science research areas: Endocrinology & Metabolism
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D management: colesevelam HCL
Creators: Ronald B Goldberg - Division of Endocrinology, Diabetes and Metabolism, Diabetes Research Institute, University of Miami Miller School of Medicine, 1450 Northwest 10th Avenue, Miami, FL 33136, USA. rgoldber@med.miami.edu
Publication Details: Current diabetes reports, Vol.9(5), pp.331-332
Publisher: United States
Academic Unit: Miller School of Medicine; Diabetes Research Institute (DRI)
Language: English
Resource Type: Journal article
PMID: 19793501
Record Identifier: 991031560220602976